Christodoulakis Antonios, Bouloukaki Izolde, Aravantinou-Karlatou Antonia, Zografakis-Sfakianakis Michail, Tsiligianni Ioanna
Department of Social Medicine, School of Medicine, University of Crete, 71500 Heraklion, Greece.
Department of Nursing, School of Health Sciences, Hellenic Mediterranean University, 71410 Heraklion, Greece.
Vaccines (Basel). 2024 Dec 13;12(12):1411. doi: 10.3390/vaccines12121411.
Healthcare professionals (HCPs) hold significant influence over public attitudes toward vaccinations. Studies suggest that HCPs are hesitant towards the coronavirus disease 2019 (COVID-19) vaccines. This hesitancy could lead to lower vaccination rates in the community. Therefore, this scoping review aimed to assess the extent of hesitancy towards COVID-19 booster doses among HCPs and identify the associated factors. A comprehensive search was conducted in the PubMed and Scopus databases from April to August 2024, using keywords related to COVID-19, vaccine hesitancy, HCPs, and booster vaccination. Studies that had been peer-reviewed, published in English after 2022, and focused on the hesitancy of the COVID-19 booster dose hesitancy among HCPs were included. Out of the 6703 studies screened, 24 studies were included. Most of the HCPs have received their initial series of COVID-19 vaccinations. However, there is a lower rate of uptake for booster doses, with hesitancy rates ranging from 12% to 66.5%. Hesitancy rates varied significantly across continents, with Asia, Africa, and Europe ranging from 19.7% to 66.5%, 27% to 46.1%, 14% to 60.2%, respectively. Hesitancy was reported to be influenced by various factors, including concerns about vaccine safety, necessity, and effectiveness of these vaccines. In addition, the hesitancy regarding booster doses was also found to be influenced by factors like age, gender, profession, and previous COVID-19. Physicians, nurses, and pharmacists exhibited vaccine hesitancy rates ranging from 12.8% to 43.7%, 26% to 37%, and 26% to 34.6%, respectively. Our review underscores the hesitancy among HCPs towards receiving booster doses across countries around the world and explores the underlying factors. These findings provide valuable insights for the design of future pandemic vaccination programs.
医疗保健专业人员（HCPs）对公众对疫苗接种的态度有着重大影响。研究表明，HCPs对2019冠状病毒病（COVID-19）疫苗存在犹豫态度。这种犹豫可能导致社区疫苗接种率降低。因此，本范围综述旨在评估HCPs对COVID-19加强针的犹豫程度，并确定相关因素。2024年4月至8月，在PubMed和Scopus数据库中进行了全面检索，使用了与COVID-19、疫苗犹豫、HCPs和加强针接种相关的关键词。纳入了2022年后以英文发表、经过同行评审且关注HCPs对COVID-19加强针犹豫情况的研究。在筛选的6703项研究中，纳入了24项研究。大多数HCPs已经接种了初始系列的COVID-19疫苗。然而，加强针的接种率较低，犹豫率在12%至66.5%之间。犹豫率在各大洲之间存在显著差异，亚洲、非洲和欧洲的犹豫率分别为19.7%至66.5%、27%至46.1%、14%至60.2%。据报道，犹豫受到多种因素的影响，包括对疫苗安全性、必要性和有效性的担忧。此外，对加强针的犹豫还受到年龄、性别、职业和既往COVID-19感染情况等因素的影响。医生、护士和药剂师的疫苗犹豫率分别为12.8%至43.7%、26%至37%和26%至34.6%。我们的综述强调了全球各国HCPs对接种加强针的犹豫态度，并探讨了潜在因素。这些发现为未来大流行疫苗接种计划的设计提供了有价值的见解。
